161 related articles for article (PubMed ID: 32831114)
1. Loss of PTEN expression is associated with PI3K pathway-dependent metabolic reprogramming in hepatocellular carcinoma.
Zhao C; Wang B; Liu E; Zhang Z
Cell Commun Signal; 2020 Aug; 18(1):131. PubMed ID: 32831114
[TBL] [Abstract][Full Text] [Related]
2. Enhanced glucose metabolism mediated by CD147 contributes to immunosuppression in hepatocellular carcinoma.
Li X; Zhang Y; Ma W; Fu Q; Liu J; Yin G; Chen P; Dai D; Chen W; Qi L; Yu X; Xu W
Cancer Immunol Immunother; 2020 Apr; 69(4):535-548. PubMed ID: 31965268
[TBL] [Abstract][Full Text] [Related]
3. All Three AKT Isoforms Can Upregulate Oxygen Metabolism and Lactate Production in Human Hepatocellular Carcinoma Cell Lines.
Tian LY; Smit DJ; Popova NV; Horn S; Velasquez LN; Huber S; Jücker M
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396845
[TBL] [Abstract][Full Text] [Related]
4. Transformation of SOX9
Chen J; Debebe A; Zeng N; Kopp J; He L; Sander M; Stiles BL
Sci Rep; 2021 Jun; 11(1):11823. PubMed ID: 34083580
[TBL] [Abstract][Full Text] [Related]
5. SIRT3 suppression resulting from the enhanced β-catenin signaling drives glycolysis and promotes hypoxia-induced cell growth in hepatocellular carcinoma cells.
Ma R; Gao QY; Chen ZT; Liao GH; Li ST; Cai JW; Luo NS; Chen H; Zhang HF
Cell Cycle; 2024 Feb; 23(4):435-447. PubMed ID: 38626328
[TBL] [Abstract][Full Text] [Related]
6. Genetic loss of Nrf1 and Nrf2 leads to distinct metabolism reprogramming of HepG2 cells by opposing regulation of the PI3K-AKT-mTOR signalling pathway.
Deng R; Zhu Y; Liu K; Zhang Q; Hu S; Wang M; Zhang Y
Bioorg Chem; 2024 Apr; 145():107212. PubMed ID: 38377819
[TBL] [Abstract][Full Text] [Related]
7. Involvement of lncRNAs in the regulation of aerobic glycolysis in hepatocellular carcinoma: Main functions, regulatory mechanisms and potential therapeutic implications (Review).
Huang Q; Liang Z; Huang Q; Li X; Xia J; Huang L; Huang LB; Ou C
Oncol Rep; 2024 Jun; 51(6):. PubMed ID: 38666534
[TBL] [Abstract][Full Text] [Related]
8. Research Progress of Warburg Effect in Hepatocellular Carcinoma.
Yang Y; Gao Y; Xiong Y; Gong Y; Lu J; Zhang Y; Wang D; Liu Z; Shi X
Front Biosci (Landmark Ed); 2024 May; 29(5):178. PubMed ID: 38812302
[TBL] [Abstract][Full Text] [Related]
9. The mitochondrial type IB topoisomerase drives mitochondrial translation and carcinogenesis.
Baechler SA; Factor VM; Dalla Rosa I; Ravji A; Becker D; Khiati S; Miller Jenkins LM; Lang M; Sourbier C; Michaels SA; Neckers LM; Zhang HL; Spinazzola A; Huang SN; Marquardt JU; Pommier Y
Nat Commun; 2019 Jan; 10(1):83. PubMed ID: 30622257
[TBL] [Abstract][Full Text] [Related]
10. TPI1-reduced extracellular vesicles mediated by Rab20 downregulation promotes aerobic glycolysis to drive hepatocarcinogenesis.
Liu BHM; Tey SK; Mao X; Ma APY; Yeung CLS; Wong SWK; Ng TH; Xu Y; Yao Y; Fung EYM; Tan KV; Khong PL; Ho DW; Ng IO; Tang AHN; Cai SH; Yun JP; Yam JWP
J Extracell Vesicles; 2021 Aug; 10(10):e12135. PubMed ID: 34401050
[TBL] [Abstract][Full Text] [Related]
11. The phosphoinositide 3-kinase regulatory subunit p85alpha can exert tumor suppressor properties through negative regulation of growth factor signaling.
Taniguchi CM; Winnay J; Kondo T; Bronson RT; Guimaraes AR; Alemán JO; Luo J; Stephanopoulos G; Weissleder R; Cantley LC; Kahn CR
Cancer Res; 2010 Jul; 70(13):5305-15. PubMed ID: 20530665
[TBL] [Abstract][Full Text] [Related]
12. Cryptocaryone induces apoptosis in human hepatocellular carcinoma cells by inhibiting aerobic glycolysis through Akt and c-Src signaling pathways.
Yu CL; Lai YW; Chen JJ; Lee JJ; Chou TH; Huang CC; Liu SC; Chen GW; Tsai CH; Wang SW
J Food Drug Anal; 2023 Dec; 31(4):696-710. PubMed ID: 38526828
[TBL] [Abstract][Full Text] [Related]
13. Research progress in the metabolic reprogramming of hepatocellular carcinoma (Review).
Gao W; Wang J; Xu Y; Yu H; Yi S; Bai C; Cong Q; Zhu Y
Mol Med Rep; 2024 Jul; 30(1):. PubMed ID: 38818815
[TBL] [Abstract][Full Text] [Related]
14. Energy stress-induced circDDX21 promotes glycolysis and facilitates hepatocellular carcinogenesis.
Luo J; Yang Y; Zhang G; Fang D; Liu K; Mei Y; Wang F
Cell Death Dis; 2024 May; 15(5):354. PubMed ID: 38773094
[TBL] [Abstract][Full Text] [Related]
15. Remodeling of Mitochondrial Plasticity: The Key Switch from NAFLD/NASH to HCC.
Longo M; Paolini E; Meroni M; Dongiovanni P
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920670
[TBL] [Abstract][Full Text] [Related]
16. [Research progress of non-coding RNA involved in glycolysis regulation of hepatocellular carcinoma].
Hu XF; Zhang Q; Liang ML; Zhou QN; Zhao RQ; Gong ZK; Lin WZ
Sheng Li Xue Bao; 2024 Apr; 76(2):319-328. PubMed ID: 38658380
[TBL] [Abstract][Full Text] [Related]
17. Icaritin activates p53 and inhibits aerobic glycolysis in liver cancer cells.
Zhou X; Wu D; Mi T; Li R; Guo T; Li W
Chem Biol Interact; 2024 Apr; 392():110926. PubMed ID: 38431053
[TBL] [Abstract][Full Text] [Related]
18. Metabolic interplay between glycolysis and mitochondrial oxidation: The reverse Warburg effect and its therapeutic implication.
Lee M; Yoon JH
World J Biol Chem; 2015 Aug; 6(3):148-61. PubMed ID: 26322173
[TBL] [Abstract][Full Text] [Related]
19. Dynamics and control of the central carbon metabolism in hepatoma cells.
Maier K; Hofmann U; Reuss M; Mauch K
BMC Syst Biol; 2010 Apr; 4():54. PubMed ID: 20426867
[TBL] [Abstract][Full Text] [Related]
20. Targeting the Warburg Effect in Cancer: Where Do We Stand?
Barba I; Carrillo-Bosch L; Seoane J
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
